Clinical trials
Do you want to participate?
Register for a specific trial
An overview of the trials for which we are currently looking for participants can be found below.
You can register on the page of the trial.
Trials open for registration
Join our mailing list
We may not be actively looking for participants at the moment, or maybe there are no trials for which you can or want to register. Join our mailing list to receive updates on future trials. We will notify you when we launch a trial for which you may be eligible. We will only use your data for this purpose.
Contact
Would you like more information about (a trial within) the Clinical Trial Site?
Contact us at infoctc@itg.beAre you a partner in academia or life sciences and interested in collaborating with the Clinical Trial Site?
Contact us at partnersctc@itg.be
Closed trials
Explore our trials-
Assessment of the immunogenicity and safety of marketed vaccines for COVID-19 after regular schedule and adapted vaccine schedules and routes: BNT162b2 (Comirnaty®; Pfizer-BioNTech), mRNA-1273 vaccine (COVID-19 vaccine Moderna®; Moderna) and COVID-19 vaccine (ChAdOx1-S [recombinant])(Vaxzevria®, AstraZeneca) -
A Randomized, Double-blind, Phase 3 Study to Evaluate Safety, Reactogenicity, and Immunogenicity of Co-administration of Ad26.COV2.S and Influenza Vaccines in Healthy Adults 18 Years of Age and Older
-
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older
-
Safety and Immunogenicity of V116 in Adults Living With Human Immunodeficiency Virus (HIV)
-
Study on a shortened administration schedule for administering the rabies vaccine.
-
Research on antibiotic resistance from our diet
-
The ITM Clinical Trial Centre is evaluating a new vaccine against COVID-19.
-
Research on how vaccination evokes better immune memory generation in your skin
-
Research into a new vaccine that works against multiple flu viruses
-
Evaluating a new immunotherapy that aims to reduce the frequency, severity and duration of genital herpes outbreaks
-
Study on the co-administration of the pneumococcal and RSV vaccines
-
Researching the simultaneous administration of the RSV and COVID-19 vaccines
-
We are investigating the effectiveness and side effects of the drug tecovirimat for the treatment of an mpox infection.
-
Research into innovative vaccination techniques for children
-
Research into a novel vaccine against influenza
-
The mpox booster trial aims to evaluate the duration of immunity following the initial mpox vaccination and determine if a booster dose is necessary for long-lasting immunity.
-
The GeKoSkimm Unvaccinated study investigates how vaccination evokes better immune memory generation against yellow fever in your skin.
